Carrier-Free Peptide-Daunorubicin-Small Interfering RNA Nanoassembly for Targeted Therapy of Acute Myeloid Leukemia
{{output}}
Acute myeloid leukemia (AML) continues to represent a substantial unmet therapeutic need in clinical practice. In recent years, peptide-drug conjugates and small interfering RNA (siRNA) drugs have gained considerable attention due to their impressive clinical ... ...
